Torben Michalsen
Chief Operating Officer at G2 GOLDFIELDS INC.
Net worth: 414 233 $ as of 2024-06-29
Network origin in Torben Michalsen first degree
Entity | Entity type | Industry | |
---|---|---|---|
Public Company | Precious Metals | 7 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Torben Michalsen via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
S2 MINERALS INC. | Other Metals/Minerals | Director/Board Member Chairman Chief Executive Officer Director of Finance/CFO Director/Board Member | |
GPM METALS INC. | Other Metals/Minerals | Founder Corporate Secretary Chairman Director of Finance/CFO Director/Board Member | |
GUYANA GOLDFIELDS INC. | Precious Metals | Founder Director/Board Member Director of Finance/CFO Director/Board Member | |
Aranka Gold, Inc.
Aranka Gold, Inc. Precious MetalsNon-Energy Minerals Part of Zijin Mining Group Co., Ltd., Aranka Gold, Inc. mines for gold. The company is based in Toronto, Canada. Aranka Gold was acquired by Guyana Goldfields, Inc. on January 28, 2009 for $14.40 million. | Precious Metals | President Director/Board Member Director of Finance/CFO | |
LUMINA GOLD CORP. | Precious Metals | Director/Board Member Director/Board Member | |
COPPER ROAD RESOURCES INC. | Precious Metals | Corporate Secretary Director of Finance/CFO | |
BE RESOURCES INC. | Other Metals/Minerals | Director/Board Member Chief Executive Officer | |
The Chartered Governance Institute
The Chartered Governance Institute Miscellaneous Commercial ServicesCommercial Services The Chartered Governance Institute provides governance and compliance services. The company was incorporated by Royal Charter in 1891 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
DSA Corporate Services, Inc. | President Director/Board Member | ||
Marrelli & Drake Corporate Services | Corporate Officer/Principal Corporate Officer/Principal | ||
DEVERON CORP. | Packaged Software | Director of Finance/CFO | |
BLUE LAGOON RESOURCES INC. | Other Metals/Minerals | Director of Finance/CFO | |
DYNACERT INC. | Trucks/Construction/Farm Machinery | Director of Finance/CFO | |
SABRE GOLD MINES CORP. | Precious Metals | Director of Finance/CFO | |
NEW FRONTIER VENTURES INC. | Miscellaneous Commercial Services | Director of Finance/CFO | |
ARANJIN RESOURCES LTD. | Other Metals/Minerals | Director of Finance/CFO | |
GLOBEX MINING ENTERPRISES INC. | Precious Metals | Director of Finance/CFO | |
Institute of Chartered Secretaries & Administrators of Canada | Corporate Officer/Principal | ||
REVIVAL GOLD INC. | Precious Metals | Director of Finance/CFO | |
TINTINA MINES LIMITED | Other Metals/Minerals | Director/Board Member | |
PHIVIDA HOLDINGS INC. | Pharmaceuticals: Other | Director of Finance/CFO | |
ROYAL STANDARD MINERALS INC. | Precious Metals | Chief Executive Officer | |
REVIVE THERAPEUTICS LTD. | Pharmaceuticals: Major | Director of Finance/CFO | |
SINTANA ENERGY INC. | Other Metals/Minerals | Director of Finance/CFO | |
MEGA URANIUM LTD. | Other Metals/Minerals | Director of Finance/CFO | |
PINETREE CAPITAL LTD. | Financial Conglomerates | Director of Finance/CFO | |
SKYLIGHT HEALTH GROUP INC. | Medical/Nursing Services | Director of Finance/CFO | |
INVENTUS MINING CORP. | Precious Metals | Director of Finance/CFO | |
MARTINA MINERALS CORP. | Precious Metals | Director of Finance/CFO | |
OUTDOORPARTNER MEDIA CORPORATION | Advertising/Marketing Services | Director/Board Member | |
OLIVE RESOURCE CAPITAL INC. | Precious Metals | Director of Finance/CFO | |
Revive Therapeutics, Inc.
Revive Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Revive Therapeutics Ltd., Revive Therapeutics, Inc. is a specialty life sciences company based in North York, CA. The company focuses on the research and development of therapeutics for rare disorders and infectious diseases. Revive Therapeutics' cannabinoid pharmaceutical portfolio focuses on rare inflammatory areas such as liver disease. Revive Therapeutics was acquired by Mercury Capital II Ltd. on January 06, 2014 for $4.67 million. The Canadian company was granted FDA orphan drug status designation for the use of CBD to treat auto-immune hepatitis and ischemia and reperfusion injury from organ transplantation. The company is also exploring the use of bucillamine for the potential treatment of infectious diseases, including COVID-19. The company was founded by Fabio Chianelli. Revive recently acquired Psilocin Pharma Corp. to advance psilocybin-based therapeutics in various diseases and disorders. | Pharmaceuticals: Major | Director of Finance/CFO | |
PTX METALS INC. | Precious Metals | Director of Finance/CFO | |
AYR WELLNESS INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
BEYOND LITHIUM INC. | Other Metals/Minerals | Director of Finance/CFO | |
HIGHROCK RESOURCES LTD. | Oil & Gas Production | Director of Finance/CFO |
Statistics
International
Canada | 46 |
United Kingdom | 2 |
United States | 2 |
Sectoral
Non-Energy Minerals | 27 |
Finance | 7 |
Health Technology | 5 |
Commercial Services | 4 |
Technology Services | 2 |
Operational
Director of Finance/CFO | 90 |
Director/Board Member | 38 |
Corporate Secretary | 34 |
Corporate Officer/Principal | 19 |
Independent Dir/Board Member | 17 |
Most connected contacts
Insiders | |
---|---|
Carmelo Marrelli | 108 |
Shaun Drake | 25 |
Daniel Noone | 16 |
Stephen Stow | 8 |
John Sheridan | 8 |
Bruce Rosenberg | 5 |
Boaz Wade | 2 |
- Stock Market
- Insiders
- Torben Michalsen
- Company connections